Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $47.37B.
ENTERPRISE VALUE (EV)
$47.37B
Edwards Lifesciences Corporation
Market Cap
$49.69B
Enterprise Value (EV)
$47.37B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Edwards Lifesciences Corporation (EW) | $49.69B | $47.37B |
| Agilent Technologies, Inc. (A)vs › | $48.80B | $50.99B |
| Becton, Dickinson and Company (BDX)vs › | $50.65B | $66.75B |
| Humana Inc. (HUM)vs › | $47.81B | $55.16B |
| Cardinal Health, Inc. (CAH)vs › | $51.58B | $56.67B |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $45.64B | $58.86B |
| IQVIA Holdings Inc. (IQV)vs › | $44.50B | $58.83B |
| Waters Corporation (WAT)vs › | $42.57B | $47.28B |
| IDEXX Laboratories, Inc. (IDXX)vs › | $40.96B | $41.86B |
| Cencora, Inc. (COR)vs › | $59.71B | $68.62B |
Market Cap
$49.69B
Total Debt
$622.80M
Cash
$2.94B
Enterprise Value
$47.37B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
